Pharmaceutical News

RSS

Combination treatment lowers risk of ischemic stroke recurrence

Stroke survivors taking a combination of the blood thinner cilostazol with aspirin or clopidogrel had a lower risk of ischemic stroke recurrence than those who received aspirin or clopidogrel alone, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

7 Feb 2019

New physical effect could lead to advancements in personalized pharmaceuticals

A new physical effect has been demonstrated at the University of Bath after 40 years of pursuit by physicists around the world, which could lead to advancements in chemical manufacturing efficiency, miniaturization and quality control in personalized pharmaceuticals.

7 Feb 2019

Review: Antibiotic development has increased, but inadequate

While the pipeline of new antibiotics has improved over the past six years, momentum in the development of new infection-fighting agents remains inadequate and could take a significant downturn without new incentives, a report released in Clinical Infectious Diseases shows.

7 Feb 2019

NSAID pretreatment promotes cardiorenal syndrome in heart failure

Non-steroidal anti-inflammatory drugs, or NSAIDs, are widely known as pain-killers and can relieve pain and inflammation. However, prolonged use raises the risk of heart and kidney failure events. A heart attack causes death of heart muscle cells by lack of oxygen, and it also significantly injures the kidneys.

7 Feb 2019

Researchers show efficacy of new therapy for amyotrophic lateral sclerosis in mice

A team from Université Laval and the CERVO Brain Research Centre has demonstrated the efficacy in mice of a new therapy that addresses the main manifestation of amyotrophic lateral sclerosis.

7 Feb 2019

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening disorder that causes blood clotting.

7 Feb 2019

New review examines impact of cancer therapies on the skeleton

A new British Journal of Clinical Pharmacology review examines the impact of cancer therapies on the skeleton and how to limit bone loss and fractures in cancer patients treated with these therapies.

6 Feb 2019

Drug cocktail may help combat breast cancer

MYC, a gene with high cancer-initiating potential, is overexpressed in over 40% of breast cancers. While MYC programs breast cancer cells to build more macromolecules (anabolic metabolism) it also creates a metabolic vulnerability by making them more sensitive to a type of cell death known as apoptosis.

6 Feb 2019

New study estimates prevalence and risk factors for misuse of prescribed opioids

A new Pharmacoepidemiology & Drug Safety study estimates the prevalence and risk factors for self-reported misuse of prescribed opioids in the general adult population.

6 Feb 2019

Study shows no difference between relief offered by topical pain creams and placebos

In an effort to reduce chronic pain, many people look for hope by paying $20 to thousands of dollars for a tube of prescription topical pain cream or gel.

6 Feb 2019

Pharmacy in future: Transformational change is essential in all practice settings

Medications improve health and saves lives, but they are not risk-free. The modern pharmacist is largely responsible for helping patients navigate an increasingly complex and costly health care system, particularly with respect to medications.

5 Feb 2019

Anti-inflammatory biologic therapy may prevent heart disease in patients with skin condition

Anti-inflammatory biologic drugs used to treat severe psoriasis have the potential to prevent heart disease in patients with the skin condition, according to research published today in Cardiovascular Research, a journal of the European Society of Cardiology.

5 Feb 2019

Researchers report psychological placebos can also have an effect

Placebo effects do not only occur in medical treatment - placebos can also work when psychological effects are attributed to them. Researchers from the University of Basel's Faculty of Psychology reported these findings in the journal Scientific Reports, based on three studies with over 400 participants.

5 Feb 2019

Drug treating breast cancer may be effective in treating lung and ovarian cancer

Two new papers, published simultaneously in Nature Communications and led by researchers at McGill University, offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer, one rare and one common form.

5 Feb 2019

Rutgers study uncovers new threat in the opiate epidemic

A Rutgers study has uncovered a new threat in the opiate epidemic: Overdoses of loperamide, an over-the-counter diarrhea medication, have been steadily increasing in number and severity nationwide over five years.

4 Feb 2019

Lawsuit details how the Sackler family allegedly built an Oxycontin fortune

The first nine months of 2013 started off as a banner year for the Sackler family, owners of the pharmaceutical company that produces OxyContin, the addictive opioid pain medication. Purdue Pharma paid the family $400 million from its profits during that time, claims a lawsuit filed by the Massachusetts attorney general.

4 Feb 2019

Opioid overdose epidemic likely to increase in the U.S in coming years

A study from investigators at the Massachusetts General Hospital Institute for Technology Assessment projects that the opioid overdose epidemic in the U.S. is likely to increase in coming years, and that measures based on restricting access to prescription opioids will have a minimal impact in reducing overdose deaths.

3 Feb 2019

UC study reveals most effective medication for treating pediatric anxiety

Researchers from the University of Cincinnati (UC) examined common medications prescribed for children and adolescents with anxiety disorders, to determine which are the most effective and best-tolerated.

1 Feb 2019

Winners and losers under bold Trump plan to slash drug rebate deals

Few consumers have heard of the secret, business-to-business payments that the Trump administration wants to ban in an attempt to control drug costs.

1 Feb 2019

Newron announces successful completion of patient enrollment in STARS study

Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced the successful completion of patient enrollment in its STARS clinical study.

1 Feb 2019

Pharmaceutical News

Combination treatment lowers risk of ischemic stroke recurrence

New physical effect could lead to advancements in personalized pharmaceuticals

Review: Antibiotic development has increased, but inadequate

NSAID pretreatment promotes cardiorenal syndrome in heart failure

Researchers show efficacy of new therapy for amyotrophic lateral sclerosis in mice

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

New review examines impact of cancer therapies on the skeleton

Drug cocktail may help combat breast cancer

New study estimates prevalence and risk factors for misuse of prescribed opioids

Study shows no difference between relief offered by topical pain creams and placebos

Pharmacy in future: Transformational change is essential in all practice settings

Anti-inflammatory biologic therapy may prevent heart disease in patients with skin condition

Researchers report psychological placebos can also have an effect

Drug treating breast cancer may be effective in treating lung and ovarian cancer

Rutgers study uncovers new threat in the opiate epidemic

Lawsuit details how the Sackler family allegedly built an Oxycontin fortune

Opioid overdose epidemic likely to increase in the U.S in coming years

UC study reveals most effective medication for treating pediatric anxiety

Winners and losers under bold Trump plan to slash drug rebate deals

Newron announces successful completion of patient enrollment in STARS study

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News